Skip to main content
. 2022 Dec 6;9:1073072. doi: 10.3389/fcvm.2022.1073072

TABLE 2.

Risk stratification models.

Name of study No. of patients(D/V) C statistic D/V (original paper) Characteristics Only preprocedural Population No. of risk factors Model variables
Bartholomew et al. (171) 20.479 (10 481/9998) 0.89 (missing 95% CL) Single center No Undergoing PCI 8 eGFR <60 ml/min, IABP, urgent/emergent procedure, diabetes, heart failure, hypertension, peripheral artery disease, contrast volume >260 ml
Marenzi et al. (172) 1.172 (218/891) 0.60 (missing 95% CL) Single center No PCI for STEMI 5 Age >75 years, anterior infarction, time to reperfusion, contrast volume, use of IABP
Mehran et al. (49) 8.357 (5571/2786) 0.67 (95% CI 0.608–0.779) Single center No PCI for STEMI 8 Hypotension, heart failure, CKD, diabetes, age >75 years, anemia, use of IABP, contrast volume
Ghani and Tohamy (173) 347 (247/100) 0.61 (missing 95%CL) Single center No Undergoing PCI 5 Basal serum creatinine >115 μmol/L, shock, female gender, multivessel PCI, and diabetes
Maioli et al. (174) 1.783 (1281/502) 0.82 (missing 95%CL) Single center Yes Undergoing CAG or PCI 7 Age >73, diabetes, LVEF 45%, creatinine 1.5 mg/dl or CrCl eGFR ≤ 45(ml/min/1.73 m2) ml/min, post hydration creatinine
Fu et al. (175) 895 (668/277) 0.79 (missing 95%CL) Single center No Undergoing PCI 9 eGFR <60 ml/min/1.73 m, diabetes, LVEF < 45%, MI, emergency PCI, myocardial infarction anemia, contrast volume >200 ml, hypotension, age > 70 years
Tziakas et al. (176) 688 (488/200) 0.76 (95%CI 0.685–0.833) Single center No Undergoing PCI 5 CKD, metformin use, prior PCI, peripheral arterial disease, contrast volume ≥ 300 ml
Gurm et al.(52) 60.573 (40,001/20,572) 0.84 (95% CI: 0.821 to 0.857) Multi center Yes Undergoing PCI 15 (reduced model) PCI indication/status, CAD presentation, cardiogenic shock, heart failure, prePCI LVEF, diabetes, age, weight, height, CK-MB, creatinine, hemoglobin, troponin I, and troponin T
Chen et al. (55) 2.500 (1500/1000) 0.82 (95% CL: 0.78-0.86) Single center Yes Undergoing PCI 9 Age ≥ 70, prior MI, diabetes, hypotension, LVEF ≤ 45%, anemia, eGFR ≤ 45(ml/min/1.73 m2), HDL < 1 mmol/, Urgent PCI
Gao et al. (177) 3.945(2.764/1181) 0.71 (95% CI 0.63–0.79) Singe center No Undergoing CAG or PCI 7 Age > 60, hypertension, acute MI, heart failure, IABP usage, CKD, contrast volume > 100 ml
Liu et al. (178) 1.272 (848/424) 0.76 (95% CI 0.685–0.832) Single center Yes Undergoing CAG or PCI 4 IABP, eGFR, Hypoalbuminemia, age
Victor et al. (179) 1.200 (900/300) 0.95 (Spec. 82%, Sens. 92%) Single center No Undergoing PCI 7 GFR value, amount of contrast, hemoglobin, diabetic microangiopathy, hypotension, albuminuria, peripheral vascular disease
Duan et al. (180) 1.777 (1076/701) 0.8 (95%CI: 0.727-0.870) Single center Yes Undergoing CAG or PCI 7 Age ≤ 70, history of myocardial infarction, diabetes, hypotension, LVEF < 45%, anaemia, eGFR
Caspi et al. (181) 1.200 (900/300) 0.81(95% CL 0.79-0.83) Single center No Undergoing PCI 7 independent predictors of AKI age ≥ 70 years, DM insulin, diuretics, anterior MI, eGFR value, Killip III-IV, IABG, LVEF ≤ 45%
Brown et al. (182) 115.633 (87 728/27 905) 0.74 (95% CI: 0.74–0.75) Multi center No Undergoing CAG or PCI 17 Diabetes, peripheral vascular disease, prior stroke, CHF, urgency status, shock, ACS, anemia, low albumin, prior AKI, CKD, prior MI, prior CABG, smoker, age, hypertension, thrombolytic use
Lian et al. (183) 1.286(756/530) 0.7 (95% CL 0,624-0,765) Single center Yes Undergoing CAG 3 age > 75 years, CHF, CrCl < 60 ml/min
Inohara et al. (184) 5.936 (3957/1979) 0.8 (95% CL 0.783-0.815) Multi center Yes Undergoing PCI 7 Age, NYHA III-IV, DM, prior PCI, hypertension, CKD, ACS
Lin et al. (185) 692 (461/231) 0.83 (95% CL 0.776-0.853) Single center No Undergoing emergent PCI 4 Hypotension, Age>75 years, IABP, SCr>1.5 mg/dl
Yuan et al. (186) 1.061 (761/300) 0.76 (95% CI: 0.672-0.841) Single center Yes Undergoing emergent PCI 5 BSA < 1.60 m2, history of TIA/stroke, WBC 15.0 × 109/L, eGFR 60 ml/min/1.73 m2, IABP usage, diuretics usage
Tsai et al. (187) 947.012 (662,504/284,508) 0.71 (95% CL 0.701, 0.716) Multi center Yes Undergoing PCI 11 Age, prior 2 weeks HF, GFR, diabetes, prior HF/CVD, NSTEMI/UA, STEMI, prior card shock or cardiac arrest, anemia, IABP
Freeman et al. (188) 16.592 (10,729/5863) 0.89 (missing 95%CL) Multi center Yes Undergoing PCI 5 Peripheral artery disease, diabetes, CKD (Cr > 2 mg/dl), heart failure, cardiogenic shock

D, derivation population, V, validation population; IABP, intraaortic balloon pump; CrCl, creatinine clearance; LVEF, left ventricular ejection fraction; CAD, coronary artery disease; PCI, percutaneous coronary intervention; CKD, chronic kidney disease; BSA, body surface area; ACS, acute coronary syndrome; CHF, chronic heart failure; UA, unstable angina pectoris; STEMI, ST-elevation myocardial infarction; NSTEMI, non-ST-elevation myocardial infarction.